Bio-Imaging appoints new president for data capture division

Bio-Imaging Technologies has appointed Peter S. Benton as president of its Phoenix Data Systems (PDS) division, a provider of electronic data capture services.

Benton will succeed William Claypool, MD, who is leaving PDS to start a pharmaceutical development consulting company, Pennmark Associates.

Benton has more than 20 years of experience, within the pharmaceutical research industry in operations, management, strategic planning and mergers and acquisitions. 

Most recently, he was chief operating officer of an eClinical technology services company, where he was responsible for overall operations, including project management, applications development, quality control, customer support and technology integration.

Previously, he was associated with Johnson & Johnson’s Pharmaceutical business, where he served as vice president of central planning.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.